Related Experiment Video

Updated: Apr 27, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K

[Cardiac resynchronization in a patient with congenitally corrected transposition of the great arteries]

Pedro Alexandre Sousa1, Diogo Cavaco2, Pedro Adragão2

  • 1Serviço de Cardiologia, Hospital de Faro, E.P.E., Faro, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|July 8, 2014
PubMed

Insights

This study details the first reported case in Portugal of cardiac resynchronization therapy for congenitally corrected transposition of the great arteries. This rare heart defect treatment involved a 31-year-old woman with heart failure.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Cardiac Electrophysiology

Background:

  • Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital heart defect.
  • ccTGA can lead to systemic ventricular dysfunction and conduction abnormalities.
  • Cardiac resynchronization therapy (CRT) use in congenital heart disease is not well-established.

Observation:

  • A 31-year-old woman with ccTGA, heart failure, and a history of two cardiac surgeries presented with a DDDR pacemaker.
  • The patient underwent successful transvenous CRT implantation.
  • This represents the first reported case of transvenous CRT in a ccTGA patient in Portugal.

Findings:

  • Successful implantation and likely clinical benefit of CRT in a complex ccTGA case.
  • Demonstrates the feasibility of transvenous CRT in patients with ccTGA and heart failure.
  • Highlights the importance of exploring advanced pacing strategies for challenging congenital heart conditions.

Implications:

  • CRT may be a viable therapeutic option for select patients with ccTGA and heart failure.
  • This case expands the understanding of CRT application in adult congenital heart disease.
  • Further research is warranted to establish CRT guidelines for ccTGA patients.

Keywords:
Acesso transvenosoCardiac resynchronization therapyCongenitally corrected transposition of the great arteriesTerapia de ressincronização cardíacaTransposição congenitamente corrigida das grandes artériasTransvenous access

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.3K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
936
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
670